Extracellular Vesicles as Biomarkers of Diseases
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biomarkers".
Deadline for manuscript submissions: 15 August 2024 | Viewed by 4139
Special Issue Editors
Interests: lipid signaling and signal transduction; prostate cancer; bone metastasis; vascular calcification; atherosclerosis; extracellular vesicles
Special Issues, Collections and Topics in MDPI journals
Interests: lipid signaling and signal transduction; prostate cancer; bone metastasis; vascular calcification; atherosclerosis; extracellular vesicles
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This issue aims at summarizing the most recent literature on extracellular vesicles (EVs) as disease biomarkers, as well as candidates for cell-free therapeutic approaches.
EVs (a terminology that encompasses microparticles, exosomes, and apoptotic bodies among others) are active players of cell-to-cell communication and convey fundamental information between cells. These microstructures contain proteins, lipids, and genetic information able to modify the phenotype and function of the target cells. EVs carry specific markers of the cell of origin, which could reveal the state of the cell and could be used to diagnose diseases. Indeed, EVs have attracted considerable interest in the metabolic diseases such as obesity or diabetes, in cardiovascular diseases field as reservoirs of molecules produced during arterial remodelling, in the pathogenesis of neuro-degenerative diseases such as Parkinson and Alzheimer’s diseases, but also in the cancer domain. In this Special Issue, we would like to receive experimental and clinical articles or reviews about how EVs can be identified as biomarkers of diseases.
Dr. Mebarek Saida
Dr. Leyre Brizuela
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular vesicles
- metabolic syndrome
- cancer
- cardiovascular diseases
- neurodegenerative diseases
- biomarkers